cas: 71320-77-9 Moclobemide 4-Chloro-N-(2-morpholinoethyl)benzamide

cas: 71320-77-9 Moclobemide 4-Chloro-N-(2-morpholinoethyl)benzamide

Moclobemide is the first of a new generation of non-hydrazine, reversible MAO-A inhibitors useful in the treatment of depression. Moclobemide is a selective inhibitor of MAO-A, allowing tyramine to be metabolized by MAO-B. In controlled studies, moclobemide was clinically superior to desipramine and showed no cholinergic or cardiovascular side-effects. A metabolite is currently under investigation for treatment of Parkinson's disease.

Product Name: Moclobemide
Synonyms: moclbemide;4-CHLORO-N[2-(4-MORPHOLINYL)ETHYL]-BENZAMIDE (MOCLOBEMIDE);Ro-11-1163, Aurorix, Manerix, Moclamine, p-Chloro-N-(2-morpholinoethyl)benzamide;MODOBEMDE;p-Chlor-N-(2-morpholinoethyl)benzamid;4-Chloro-(2-(4-morpholinyl)ethyl)benzamide;Moclobemide (base and/or unspecified salts);4-Chloro-N-[2-(4-morpholinyl)ethyl]benzamide, Aurorix, Moclamine
CAS: 71320-77-9
MF: C13H17ClN2O2
MW: 268.74
Melting point: 137°C
Boiling point: 447.7±40.0 °C
Storage temp.: Room temp